Research advances in China improve health globally
September / October 2015 | Volume 14, Issue 5
© 1986 Andrea Fisch, courtesy of Photoshare
Two elderly women in China.
by Shana Potash
With its ancient tradition of herbal remedies, combined with its cutting-edge biomedical research enterprise, China offers unique opportunities to advance scientific discoveries and improve health across the globe. China has been a valuable partner with the U.S. in medical research for more than 30 years.
NIH-funded scientists and colleagues at universities and health agencies in China continue to work together to better understand the cause of illnesses; find ways to improve treatments; and prevent and control the spread of infectious diseases. By studying traditional Chinese medicine, scientists have rediscovered valuable therapies, including a botanical that is the best weapon against malaria.
China is the world's most populous country, with 1.4 billion diverse residents spread across a vast and varied terrain. It has more elderly than any other country; different disease patterns, diet and lifestyle; and has experienced rapid economic growth that's impacted health.
Life expectancy in China today is about 75 years, nearly twice what it was only a half century ago. As China's population ages, noncommunicable diseases are becoming more of a concern. And, while the country has experienced economic gains, Chinese people are aging at income levels that are still lower than many industrialized countries. NIH is supporting a large-scale health and retirement survey in China to contribute to the understanding of global aging issues.
Cancer has been the focus of much of NIH's collaboration in China. NIH scientists are studying cancers that are more common there than in the U.S., such as those of the liver, biliary tract, stomach and esophagus. Many of the research endeavors began decades ago with the release of the Atlas of Cancer Mortality in the People's Republic of China, which revealed geographical patterns of cancer. Published in both Chinese and English, the findings were used in China for cancer control and research, and by scientists elsewhere who were studying, for example, how diet and the environment influence health.
More recently, NIH scientists have worked with their Chinese counterparts to recruit participants in large-scale population studies that provide a wealth of health data to interpret. The ongoing Shanghai Women's and Men's Studies have yielded valuable insights into the increased risk some genetic and lifestyle factors pose for causing cancer and other chronic diseases.
Stroke, the leading cause of death in China, is another significant research area. Also, infectious diseases including HIV/AIDS, influenza and malaria are the subject of NIH-supported research and training projects to build capacity, which helps prevent the spread of disease within the country and beyond its borders.
Resources and background information on NIH-supported research in China.
Chinese health and research information and resources from other organizations.
Resources and publications related to this article:
Resources and publications related to Chinese researchers discovered effectiveness of artemisinin against malaria:
- The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
Nature Medicine, October 2011
- Artemisinin: Discovery from the Chinese Herbal Garden
Cell, September 16, 2011 (published online September 9, 2011)
- From bark to weed: the history of artemisinin
Parasite, August 2011 (published online August 15, 2011)
- Ancient Chinese anti-fever cure becomes panacea for malaria: An interview with Zhou Yiqing
Bulletin of the World Health Organization (WHO), October 2009
- Discovery, mechanisms of action and combination therapy of artemisinin
Expert Review of Anti-infective Therapy, October 2009
- Qinghaosu (Artemisinin): An Antimalarial Drug From China
Science, May 31, 1985
- Antimalaria studies on qinghaosu
Chinese Medical Journal, December 1979
Resources and publications related to Arsenic added to cancer therapy after studies in China:
- Acute promyelocytic leukemia: where did we start, where are we now, and the future
Blood Cancer Journal, April 2015 (published online April 17, 2015)
- Provocative pearls in diagnosing and treating acute promyelocytic leukemia
Oncology, July 2012
- Arsenic trioxide in acute promyelocytic leukemia: potion not poison
Expert Review Anticancer Therapy, September 2011
- Chinese Folk Treatment Reveals Power of Arsenic to Treat Cancer, New Studies Under Way
Journal of the National Cancer Institute, May 2, 2007
- Supplement: Arsenic Trioxide
The Oncologist - Supplement 2, April 2001
Resources and publications related to Benzene research in China informs EPA regulation:
- NIH resources:
- Related publications:
- A retrospective cohort study of cause-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers
International Journal of Cancer, November 2015 (published online June 16, 2015)
- Occupational Exposure to Benzene and Chromosomal Structural Aberrations in the Sperm of Chinese Men
Environmental Health Perspectives, November 15, 2011
- Benzene Exposure Near the U.S. Permissible Limit Is Associated with Sperm Aneuploidy
Environmental Health Perspectives, June 2010
- EPA Rule Slashes Toxics from Gasoline, Vehicles, and Portable Fuel Containers
EPA news, February 9, 2007
- Hematoxicity in workers exposed to low levels of benzene
Science, December 3, 2004
- Benzene and the dose-related incidence of hematologic neoplasms in China
Journal of the National Cancer Institute, July 16, 1997
Resources and publications related to Asian diet examined for clues to improve health:
- NIH resources:
- Related publications:
Resources and publications related to Chinese study shows folic acid helps reduce stroke risk:
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.